Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Fabien Zoulim
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Disorders
Physiology
Procedures
Sign-in to see full Profile
Network (preview)
57
Trépo, Christian
33
Trepo, Christian
31
Pichoud, Christian
23
Chevallier, Michèle
21
Durantel, David
18
Hantz, Olivier
10
Jamard, Catherine
9
Parvaz, Parviz
9
Chevallier, Philippe
7
Borel, Christelle
7
Cova, Lucyna
6
Pradat, Pierre
6
Chemin, Isabelle
6
Carrouée-Durantel, Sandra
6
Escuret, Vanessa
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Fabien Zoulim (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Chemin I; Zoulim F
Hepatitis B virus induced hepatocellular carcinoma.
Cancer letters 2009;286(1):52-9.
-
2009: Zoulim Fabien; Locarnini Stephen
Hepatitis B virus resistance to nucleos(t)ide analogues.
Gastroenterology 2009;137(5):1593-608.e1-2.
-
2009: Cotte L; Chevallier Queyron P; Schlienger I; Trabaud M-A; Brochier C; André P; Zoulim F
Sexually transmitted HCV infection and reinfection in HIV-infected homosexual men.
Gastroentérologie clinique et biologique 2009;33(10-11):977-80.
-
2009: Ndongo Ndiémé; Rechoum Yassine; De Sequeira Sylvie; Zoulim Fabien; Trépo Christian; Drouet Emmanuel; Petit Marie-Anne
Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody.
Journal of medical virology 2009;81(10):1726-33.
-
2009: Bartosch Birke; Thimme Robert; Blum Hubert E; Zoulim Fabien
Hepatitis C virus-induced hepatocarcinogenesis.
Journal of hepatology 2009;51(4):810-20.
-
2009: Trépo C; Zoulim F
[Treatment of hepatitis B: new perspectives]
Gastroentérologie clinique et biologique 2009;33(8-9):811-7.
-
2009: Borgniet Olivier; Parvaz Parviz; Bouix Cécile; Chevallier Philippe; Trépo Christian; André Patrice; Zoulim Fabien
Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
Journal of medical virology 2009;81(8):1336-42.
-
2009: Liu Yan; Wang Chun-mei; Cheng Jun; Liang Zhao-ling; Zhong Yan-wei; Ren Xiao-qiang; Xu Zhi-hui; Zoulim Fabien; Xu Dong-ping
Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.
Chinese medical journal 2009;122(13):1585-6.
-
2009: Delang Leen; Paeshuyse Jan; Vliegen Inge; Leyssen Pieter; Obeid Susan; Durantel David; Zoulim Fabien; Op de Beeck Anne; Neyts Johan
Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development.
Hepatology (Baltimore, Md.) 2009;50(1):6-16.
-
2009: Chaubo Catherine; Hot Arnaud; Chevallier-Queyron Philippe; Ritter Jacques; Scoazec Jean-Yves; Zoulim Fabien; Karamé Alexandre; Brunet Maria; Touraine Jean-Louis; Morelon Emmanuel
Kidney transplant and cryptic hepatitis.
Lancet 2009;373(9680):2082.
-
2009: Si Ahmed Si Nafa; Zoulim Fabien
Pathobiology of HBV mutants and clinical impact for treatment monitoring.
Expert review of anti-infective therapy 2009;7(3):309-20.
-
2009: Covic Adrian; Abramowicz Daniel; Bruchfeld Annette; Leroux-Roels Geert; Samuel Didier; van Biesen Wim; Zoccali Carmine; Zoulim Fabien; Vanholder Raymond;
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(3):719-27.
-
2009: Zoulim Fabien; Parvaz Parviz; Marcellin Patrick; Zarski Jean-Pierre; Beaugrand Michel; Benhamou Yves; Bailly François; Maynard Marianne; Trepo Christian; Trylesinski Aldo; Monchecourt Françoise;
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure.
Liver international : official journal of the International Association for the Study of the Liver 2009;29(3):420-6.
-
2009: Dreux Marlène; Dao Thi Viet Loan; Fresquet Judith; Guérin Maryse; Julia Zélie; Verney Géraldine; Durantel David; Zoulim Fabien; Lavillette Dimitri; Cosset François-Loïc; Bartosch Birke
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
PLoS pathogens 2009;5(2):e1000310.
-
2009: Zoulim Fabien; Durantel David; Deny Paul
Management and prevention of drug resistance in chronic hepatitis B.
Liver international : official journal of the International Association for the Study of the Liver 2009;29 Suppl 1():108-15.
-
2009: Liu Yan; Zhao Jian-Jun; Wang Chun-mei; Li Mian-yang; Han Ping; Wang Lin; Cheng Yong-qian; Zoulim Fabien; Ma Xu; Xu Dong-ping
Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line.
Chinese medical journal 2009;122(1):10-4.
-
2009: Villet Stéphanie; Billioud Gaëtan; Pichoud Christian; Lucifora Julie; Hantz Olivier; Sureau Camille; Dény Paul; Zoulim Fabien
In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
Gastroenterology 2009;136(1):168-176.e2.
-
2009: Santantonio Teresa; Fasano Massimo; Durantel Sandra; Barraud Luc; Heichen Manuela; Guastadisegni Angela; Pastore Giuseppe; Zoulim Fabien
Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B.
Antiviral therapy 2009;14(4):557-65.
-
2009: Vincent Isabelle E; Lucifora Julie; Durantel David; Hantz Olivier; Chemin Isabelle; Zoulim Fabien; Trepo Christian
Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Antiviral therapy 2009;14(1):131-5.
-
2008: Alotte Christine; Martin Amaury; Caldarelli Sergio A; Di Giorgio Audrey; Condom Roger; Zoulim Fabien; Durantel David; Hantz Olivier
Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Antiviral research 2008;80(3):280-7.
-
2008: Zoulim Fabien; Radenne Sylvie; Ducerf Christian
Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14 Suppl 2():S1-7.
-
2008: Raimondo Giovanni; Allain Jean-Pierre; Brunetto Maurizia R; Buendia Marie-Annick; Chen Ding-Shinn; Colombo Massimo; Craxì Antonio; Donato Francesco; Ferrari Carlo; Gaeta Giovanni B; Gerlich Wolfram H; Levrero Massimo; Locarnini Stephen; Michalak Thomas; Mondelli Mario U; Pawlotsky Jean-Michel; Pollicino Teresa; Prati Daniele; Puoti Massimo; Samuel Didier; Shouval Daniel; Smedile Antonina; Squadrito Giovanni; Trépo Christian; Villa Erica; Will Hans; Zanetti Alessandro R; Zoulim Fabien
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
Journal of hepatology 2008;49(4):652-7.
-
2008: Margeridon Séverine; Carrouée-Durantel Sandra; Chemin Isabelle; Barraud Luc; Zoulim Fabien; Trépo Christian; Kay Alan
Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA.
Antimicrobial agents and chemotherapy 2008;52(9):3068-73.
-
2008: Soriano Vincent; Puoti Massimo; Peters Marion; Benhamou Yves; Sulkowski Mark; Zoulim Fabien; Mauss Stefan; Rockstroh Juergen
Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
AIDS (London, England) 2008;22(12):1399-410.
-
2008: Soriano Vincent; Perelson Alan S; Zoulim Fabien
Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?
The Journal of antimicrobial chemotherapy 2008;62(1):1-4.
-
2008: Thermet Alexandre; Buronfosse Thierry; Werle-Lapostolle Bettina; Chevallier Michele; Pradat Pierre; Trepo Christian; Zoulim Fabien; Cova Lucyna
DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection.
The Journal of general virology 2008;89(Pt 5):1192-201.
-
2008: Villet Stéphanie; Pichoud Christian; Billioud Gaëtan; Barraud Luc; Durantel Sandra; Trépo Christian; Zoulim Fabien
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure.
Journal of hepatology 2008;48(5):747-55.
-
2008: Pawlotsky Jean-Michel; Dusheiko Geoffrey; Hatzakis Angelos; Lau Daryl; Lau George; Liang T Jake; Locarnini Stephen; Martin Paul; Richman Douglas D; Zoulim Fabien
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.
Gastroenterology 2008;134(2):405-15.
-
2008: Zoulim Fabien
[Current data on the treatment of chronic hepatitis B]
Presse médicale (Paris, France : 1983) 2008;37(2 Pt 2):287-93.
-
2008: Cooksley Helen; Chokshi Shilpa; Maayan Yafit; Wedemeyer Heiner; Andreone Pietro; Gilson Richard; Warnes Thomas; Paganin Simona; Zoulim Fabien; Frederick David; Neumann Avidan U; Brosgart Carol L; Naoumov Nikolai V
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.
Antimicrobial agents and chemotherapy 2008;52(1):312-20.
-
2008: Lacombe Karine; Gozlan Joël; Boyd Anders; Boelle Pierre-Yves; Bonnard Philippe; Molina Jean-Michel; Miailhes Patrick; Lascoux-Combe Caroline; Serfaty Lawrence; Zoulim Fabien; Girard Pierre-Marie
Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients.
Antiviral therapy 2008;13(5):705-13.
-
2008: Carrouée-Durantel Sandra; Durantel David; Werle-Lapostolle Bettina; Pichoud Christian; Naesens Lieve; Neyts Johan; Trépo Christian; Zoulim Fabien
Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants.
Antiviral therapy 2008;13(3):381-8.
-
2008: Zoulim Fabien; Perrillo Robert
Hepatitis B: reflections on the current approach to antiviral therapy.
Journal of hepatology 2008;48 Suppl 1():S2-19.
-
2007: Durantel David; Zoulim Fabien
Learning from HIV: how will drug resistance influence treatment strategies against hepatitis C?
Journal of HIV therapy 2007;12(4):88-91.
-
2007: Manns Michael P; Foster Graham R; Rockstroh Jürgen K; Zeuzem Stefan; Zoulim Fabien; Houghton Michael
The way forward in HCV treatment--finding the right path.
Nature reviews. Drug discovery 2007;6(12):991-1000.
-
2007: Thibault Vincent; Pichoud Christian; Mullen Carolyn; Rhoads James; Smith Jane B; Bitbol Alain; Thamm Sven; Zoulim Fabien
Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infections.
Journal of clinical microbiology 2007;45(12):3948-53.
-
2007: Sheldon Julie; Ramos Belen; Garcia-Samaniego Javier; Rios Pilar; Bartholomeusz Angeline; Romero Miriam; Locarnini Stephen; Zoulim Fabien; Soriano Vincent
Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):279-82.
-
2007: Fournier Claire; Zoulim Fabien
Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
Clinics in liver disease 2007;11(4):869-92, ix.
-
2007: Lazar Catalin; Durantel David; Macovei Alina; Zitzmann Nicole; Zoulim Fabien; Dwek Raymond A; Branza-Nichita Norica
Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Antiviral research 2007;76(1):30-7.
-
2007: Miailhes Patrick; Trabaud Mary-Anne; Pradat Pierre; Lebouché Bertrand; Chevallier Michèle; Chevallier Philippe; Zoulim Fabien; Trepo Christian
Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(5):624-32.
-
2007: Li Ke; Zoulim Fabien; Pichoud Christian; Kwei Karen; Villet Stéphanie; Wands Jack; Li Jisu; Tong Shuping
Critical role of the 36-nucleotide insertion in hepatitis B virus genotype G in core protein expression, genome replication, and virion secretion.
Journal of virology 2007;81(17):9202-15.
-
2007: Keeffe Emmet B; Zeuzem Stefan; Koff Raymond S; Dieterich Douglas T; Esteban-Mur Rafael; Gane Edward J; Jacobson Ira M; Lim Seng G; Naoumov Nikolai; Marcellin Patrick; Piratvisuth Teerha; Zoulim Fabien
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(8):890-7.
-
2007: Mrani S; Chemin I; Menouar K; Guillaud O; Pradat P; Borghi G; Trabaud M A; Chevallier P; Chevallier M; Zoulim F; Trépo C
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.
Journal of medical virology 2007;79(8):1075-81.
-
2007: Kay Alan; Zoulim Fabien
Hepatitis B virus genetic variability and evolution.
Virus research 2007;127(2):164-76.
-
2007: Lok Anna S; Zoulim Fabien; Locarnini Stephen; Bartholomeusz Angeline; Ghany Marc G; Pawlotsky Jean-Michel; Liaw Yun-Fan; Mizokami Masashi; Kuiken Carla;
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
Hepatology (Baltimore, Md.) 2007;46(1):254-65.
-
2007: Brunelle M N; Lucifora J; Neyts J; Villet S; Holy A; Trepo C; Zoulim F
In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants.
Antimicrobial agents and chemotherapy 2007;51(6):2240-3.
-
2007: Zoulim Fabien
Emerging drugs for hepatitis B.
Expert opinion on emerging drugs 2007;12(2):199-217.
-
2007: Chapel Cynthia; Garcia Céline; Bartosch Birke; Roingeard Philippe; Zitzmann Nicole; Cosset François-Loïc; Dubuisson Jean; Dwek Raymond A; Trépo Christian; Zoulim Fabien; Durantel David
Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
The Journal of general virology 2007;88(Pt 4):1133-43.
-
2007: Villet Stéphanie; Ollivet Aurélie; Pichoud Christian; Barraud Luc; Villeneuve Jean-Pierre; Trépo Christian; Zoulim Fabien
Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient.
Journal of hepatology 2007;46(3):531-8.
-
2007: Durantel David; Alotte Christine; Zoulim Fabien
Glucosidase inhibitors as antiviral agents for hepatitis B and C.
Current opinion in investigational drugs (London, England : 2000) 2007;8(2):125-9.
-
2007: Durantel David; Zoulim Fabien
Going towards more relevant cell culture models to study the in vitro replication of serum-derived hepatitis C virus and virus/host cell interactions?
Journal of hepatology 2007;46(1):1-5.
-
2007: Poynard Thierry; Morra Rachel; Halfon Philippe; Castera Laurent; Ratziu Vlad; Imbert-Bismut Françoise; Naveau Sylvie; Thabut Dominique; Lebrec Didier; Zoulim Fabien; Bourliere Marc; Cacoub Patrice; Messous Djamila; Munteanu Mona; de Ledinghen Victor
Meta-analyses of FibroTest diagnostic value in chronic liver disease.
BMC gastroenterology 2007;7():40.
-
2006: Zoulim Fabien
Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?
Hepatology (Baltimore, Md.) 2006;44(6):1404-7.
-
2006: Escuret Vanessa; Martin Amaury; Durantel David; Parent Romain; Hantz Olivier; Trépo Christian; Menguy Thierry; Bottius Emmanuel; Dardy Jerome; Maral Jean; Escary Jean Louis; Zoulim Fabien
Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system.
Antimicrobial agents and chemotherapy 2006;50(12):3984-91.
-
2006: Lacombe Karine; Ollivet Aurélie; Gozlan Joel; Durantel Sandra; Tran Nathalie; Girard Pierre-Marie; Zoulim Fabien
A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient.
AIDS (London, England) 2006;20(17):2229-31.
-
2006: Zoulim Fabien
New nucleic acid diagnostic tests in viral hepatitis.
Seminars in liver disease 2006;26(4):309-17.
-
2006: Narayan Ramamurthy; Buronfosse Thierry; Schultz Ursula; Chevallier-Gueyron Philippe; Guerret Sylviane; Chevallier Michelle; Saade Fadi; Ndeboko Benedicte; Trepo Christian; Zoulim Fabien; Cova Lucyna
Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.
The Journal of general virology 2006;87(Pt 11):3225-32.
-
2006: Zoulim Fabien
[Definitions of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B]
Gastroentérologie clinique et biologique 2006;30(10 Pt 2):3S9-11.
-
2006: Villet Stéphanie; Pichoud Christian; Villeneuve Jean-Pierre; Trépo Christian; Zoulim Fabien
Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.
Gastroenterology 2006;131(4):1253-61.
-
2006: Diaz Olivier; Delers François; Maynard Marianne; Demignot Sylvie; Zoulim Fabien; Chambaz Jean; Trépo Christian; Lotteau Vincent; André Patrice
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.
The Journal of general virology 2006;87(Pt 10):2983-91.
-
2006: Zoulim Fabien
Antiviral therapy of chronic hepatitis B.
Antiviral research 2006;71(2-3):206-15.
-
2006: Tran N; Berne R; Chann R; Gauthier M; Martin D; Armand M-A; Ollivet A; Teo C G; Ijaz S; Flichman D; Brunetto M; Bielawski K P; Pichoud C; Zoulim F; Vernet G
European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypes.
Journal of clinical microbiology 2006;44(8):2792-800.
-
2006: Sheldon J; Rodès B; Zoulim F; Bartholomeusz A; Soriano V
Mutations affecting the replication capacity of the hepatitis B virus.
Journal of viral hepatitis 2006;13(7):427-34.
-
2006: Lobato Cirley; Tavares-Neto José; Rios-Leite Márcio; Trepo Christian; Vitvitski Ludmila; Parvaz Parviz; Zoulim Fabien; D'Oliveira Argemiro; Paraná Raymundo
Intrafamilial prevalence of hepatitis B virus in Western Brazilian Amazon region: epidemiologic and biomolecular study.
Journal of gastroenterology and hepatology 2006;21(5):863-8.
-
2006: Zoulim Fabien
In vitro models for studying hepatitis B virus drug resistance.
Seminars in liver disease 2006;26(2):171-80.
-
2006: Zoulim Fabien
Entecavir: a new treatment option for chronic hepatitis B.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):8-12.
-
2006: Schorr Olivier; Borel Christelle; Trepo Christian; Zoulim Fabien; Hantz Olivier
Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
Journal of hepatology 2006;44(5):842-7.
-
2006: Abouzid Karima; Ndeboko Benedicte; Durantel Sandra; Jamard Catherine; Zoulim Fabien; Buronfosse Thierry; Cova Lucyna
Genetic vaccination for production of DNA-designed antibodies specific to Hepadnavirus envelope proteins.
Vaccine 2006;24(21):4615-7.
-
2006: Zoulim F; Poynard T; Degos F; Slama A; El Hasnaoui A; Blin P; Mercier F; Deny P; Landais P; Parvaz P; Trepo C;
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine.
Journal of viral hepatitis 2006;13(4):278-88.
-
2006: Chapel Cynthia; Garcia Céline; Roingeard Philippe; Zitzmann Nicole; Dubuisson Jean; Dwek Raymond A; Trépo Christian; Zoulim Fabien; Durantel David
Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
The Journal of general virology 2006;87(Pt 4):861-71.
-
2006: Jacquard A-C; Brunelle M-N; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
Antimicrobial agents and chemotherapy 2006;50(3):955-61.
-
2006: Zoulim Fabien
[New virologic tests and their application in management of chronic hepatitis B]
Presse médicale (Paris, France : 1983) 2006;35(2 Pt 2):317-26.
-
2006: Lacombe Karine; Massari Véronique; Girard Pierre-Marie; Serfaty Lawrence; Gozlan Joël; Pialoux Gilles; Mialhes Patrick; Molina Jean-Michel; Lascoux-Combe Caroline; Wendum Dominique; Carrat Fabrice; Zoulim Fabien
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.
AIDS (London, England) 2006;20(3):419-27.
-
2006: Zoulim Fabien
Assessment of treatment efficacy in HBV infection and disease.
Journal of hepatology 2006;44(1 Suppl):S95-9.
-
2005: Durantel David; Brunelle Marie-Noelle; Gros Edwige; Carrouée-Durantel Sandra; Pichoud Christian; Villet Stephanie; Trepo Christian; Zoulim Fabien
Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34 Suppl 1():S34-43.
-
2005: Escuret Vanessa; Aucagne Vincent; Joubert Nicolas; Durantel David; Rapp Kimberly L; Schinazi Raymond F; Zoulim Fabien; Agrofoglio Luigi A
Synthesis of 5-haloethynyl- and 5-(1,2-dihalo)vinyluracil nucleosides: antiviral activity and cellular toxicity.
Bioorganic & medicinal chemistry 2005;13(21):6015-24.
-
2005: Caldarelli Sergio A; Mehiri Mohamed; Di Giorgio Audrey; Martin Amaury; Hantz Olivier; Zoulim Fabien; Terreux Raphael; Condom Roger; Patino Nadia
A cyclic PNA-based compound targeting domain IV of HCV IRES RNA inhibits in vitro IRES-dependent translation.
Bioorganic & medicinal chemistry 2005;13(20):5700-9.
-
2005: Poynard Thierry; Zoulim Fabien; Ratziu Vlad; Degos Françoise; Imbert-Bismut Francoise; Deny Paul; Landais Paul; El Hasnaoui Abdelkader; Slama Alain; Blin Patrick; Thibault Vincent; Parvaz Parviz; Munteanu Mona; Trepo Christian
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
The American journal of gastroenterology 2005;100(9):1970-80.
-
2005: Bizollon Thierry; Pradat Pierre; Mabrut Jean-Yves; Chevallier Michelle; Adham Mustapha; Radenne Sylvie; Souquet Jean-Christophe; Ducerf Christian; Baulieux Jacques; Zoulim Fabien; Trepo Christian
Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(8):1909-13.
-
2005: Brunelle Marie-Noëlle; Jacquard Anne-Carole; Pichoud Christian; Durantel David; Carrouée-Durantel Sandra; Villeneuve Jean-Pierre; Trépo Christian; Zoulim Fabien
Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.
Hepatology (Baltimore, Md.) 2005;41(6):1391-8.
-
2005: Margeridon Séverine; Lachaux Alain; Trepo Christian; Zoulim Fabien; Kay Alan
A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus.
The Journal of general virology 2005;86(Pt 6):1687-93.
-
2005: Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;33(2):150-7.
-
2005: Lacombe Karine; Gozlan Joël; Boelle Pierre-Yves; Serfaty Lawrence; Zoulim Fabien; Valleron Alain-Jacques; Girard Pierre-Marie
Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate.
AIDS (London, England) 2005;19(9):907-15.
-
2005: Zoulim Fabien
Combination of nucleoside analogues in the treatment of chronic hepatitis B virus infection: lesson from experimental models.
The Journal of antimicrobial chemotherapy 2005;55(5):608-11.
-
2005: Escuret Vanessa; Zoulim Fabien
[Treatment of hepatitis C]
La Revue du praticien 2005;55(6):633-45.
-
2005: Zoulim Fabien
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.
Journal of hepatology 2005;42(3):302-8.
-
2005: Bizollon Thierry; Adham Mustapha; Pradat Pierre; Chevallier Michelle; Ducerf Christian; Baulieux Jacques; Zoulim Fabian; Trepo Christian
Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C.
Transplantation 2005;79(3):325-9.
-
2005: Maynard Marianne; Parvaz Parviz; Durantel Sandra; Chevallier Michèle; Chevallier Philippe; Lot Muriel; Trepo Christian; Zoulim Fabien
Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure.
Journal of hepatology 2005;42(2):279-81.
-
2005: Robaczewska Magdalena; Narayan Ramamurthy; Seigneres Beatrice; Schorr Olivier; Thermet Alexandre; Podhajska Anna J; Trepo Christian; Zoulim Fabien; Nielsen Peter E; Cova Lucyna
Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA).
Journal of hepatology 2005;42(2):180-7.
-
2005: Bang Genie; Kim Kyun-Hwan; Guarnieri Michael; Zoulim Fabien; Kawai Shigenobu; Li Jisu; Wands Jack; Tong Shuping
Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion.
Virology 2005;332(1):216-24.
-
2004: Rocca Pierre; Codes Liana; Chevallier Michèle; Trépo Christian; Zoulim Fabien
[Autoimmunization induced by interferon alpha therapy in chronic hepatitis C]
Gastroentérologie clinique et biologique 2004;28(11):1173-6.
-
2004: Zoulim Fabien
Antiviral therapy of chronic hepatitis B: can we clear the virus and prevent drug resistance?
Antiviral chemistry & chemotherapy 2004;15(6):299-305.
-
2004: Sève Pascal; Renaudier Philippe; Sasco Annie J; Dumontet Charles; Salles Gilles; Coiffier Bertrand; Zoulim Fabien; Broussolle Christiane; Trépo Christian
Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France.
European journal of gastroenterology & hepatology 2004;16(12):1361-5.
-
2004: Locarnini Stephen; Hatzakis Angelos; Heathcote Jenny; Keeffe Emmet B; Liang T Jake; Mutimer David; Pawlotsky Jean-Michel; Zoulim Fabien
Management of antiviral resistance in patients with chronic hepatitis B.
Antiviral therapy 2004;9(5):679-93.
-
2004: Rocca Pierre; El Jastimi Saïd; Troncy Jacques; Scoazec Jean-Yves; Boucher Alexandra; Vial Thierry; Trépo Christian; Zoulim Fabien
[Imatinib mesylate-induced acute cytolytic hepatitis]
Gastroentérologie clinique et biologique 2004;28(10 Pt 1):918-9.
-
2004: Zoulim Fabien
Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.
Antiviral research 2004;64(1):1-15.
-
2004: Durantel David; Carrouée-Durantel Sandra; Werle-Lapostolle Bettina; Brunelle Marie-Noëlle; Pichoud Christian; Trépo Christian; Zoulim Fabien
A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus.
Hepatology (Baltimore, Md.) 2004;40(4):855-64.
-
2004: Vuillermoz I; Khattab E; Sablon E; Ottevaere I; Durantel D; Vieux C; Trepo C; Zoulim Fabien
Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy.
Journal of medical virology 2004;74(1):41-53.
-
2004: Jeantet Damien; Chemin Isabelle; Mandrand Bernard; Tran Albert; Zoulim Fabien; Merle Philippe; Trepo Christian; Kay Alan
Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.
Journal of medical virology 2004;73(4):508-15.
-
2004: Jacquard A C; Nassal M; Pichoud C; Ren S; Schultz U; Guerret S; Chevallier M; Werle B; Peyrol S; Jamard C; Rimsky L T; Trepo C; Zoulim F
Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
Antimicrobial agents and chemotherapy 2004;48(7):2683-92.
-
2004: Werle-Lapostolle Bettina; Bowden Scott; Locarnini Stephen; Wursthorn Karsten; Petersen Jorg; Lau George; Trepo Christian; Marcellin Patrick; Goodman Zachary; Delaney William E; Xiong Shelly; Brosgart Carol L; Chen Shan-Shan; Gibbs Craig S; Zoulim Fabien
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.
Gastroenterology 2004;126(7):1750-8.
-
2004: Zoulim Fabien; Tong ShuPing; Trépo Christian
Study of HBV replication capacity in relation to sequence variation in the precore and core promoter regions.
Methods in molecular medicine 2004;95():235-46.
-
2004: Cova Lucyna; Zoulim Fabien
Duck hepatitis B virus model in the study of hepatitis B virus.
Methods in molecular medicine 2004;96():261-8.
-
2004: Hantz Olivier; Zoulim Fabien
Duck hepatitis B virus primary hepatocyte culture model.
Methods in molecular medicine 2004;96():189-97.
-
2003: Zoulim Fabien
Treatment of pre- and post-liver transplantation HBV infection: Should we aim at combination therapy?
Hepatology (Baltimore, Md.) 2003;38(6):1353-5.
-
2003: Villeneuve Jean-Pierre; Durantel David; Durantel Sandra; Westland Christopher; Xiong Shelly; Brosgart Carol L; Gibbs Craig S; Parvaz Parviz; Werle Bettina; Trépo Christian; Zoulim Fabien
Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.
Journal of hepatology 2003;39(6):1085-9.
-
2003: Durantel David; Escuret Vanessa; Zoulim Fabien
Current and emerging therapeutic approaches to hepatitis C infection.
Expert review of anti-infective therapy 2003;1(3):441-54.
-
2003: Sablon Erwin; Shapiro Fred; Zoulim Fabien
Early detection of hepatitis B drug resistance: implications for patient management.
Expert review of molecular diagnostics 2003;3(5):535-47.
-
2003: Saito Yoshio; Escuret Vanessa; Durantel David; Zoulim Fabien; Schinazi Raymond F; Agrofoglio Luigi A
Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon.
Bioorganic & medicinal chemistry 2003;11(17):3633-9.
-
2003: Parekh Sameer; Zoulim Fabien; Ahn Sang Hoon; Tsai Adrienne; Li Jisu; Kawai Shigenobu; Khan Nasser; Trépo Christian; Wands Jack; Tong Shuping
Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.
Journal of virology 2003;77(12):6601-12.
-
2003: Zoulim Fabien
Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?
Journal of hepatology 2003;38(6):850-2.
-
2003: Seignères Béatrice; Martin Perrine; Werle Bettina; Schorr Olivier; Jamard Catherine; Rimsky Laurence; Trépo Christian; Zoulim Fabien
Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
Antimicrobial agents and chemotherapy 2003;47(6):1842-52.
-
2003: Salmon-Céron Dominique; Lassalle Régis; Pruvost Alain; Benech Henri; Bouvier-Alias Magali; Payan Christopher; Goujard Cécile; Bonnet Eric; Zoulim Fabien; Morlat Philippe; Sogni Philippe; Pérusat Sophie; Tréluyer Jean-Marc; Chêne Geneviève;
Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(10):1295-304.
-
2003: Rocca Pierre; Bailly François; Chevallier Michèle; Chevallier Philippe; Zoulim Fabien; Trépo Christian
[Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients]
Gastroentérologie clinique et biologique 2003;27(3 Pt 1):294-9.
-
2003: Le Guerhier Franck; Thermet Alexandre; Guerret Sylvianne; Chevallier Michèle; Jamard Catherine; Gibbs Craig S; Trépo Christian; Cova Lucyna; Zoulim Fabien
Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.
Journal of hepatology 2003;38(3):328-34.
-
2003: Zoulim Fabien
[New therapeutic advances in chronic hepatitis B]
Gastroentérologie clinique et biologique 2003;27(2):151-3.
-
2003: Bizollon T; Ahmed S N S; Radenne S; Chevallier M; Chevallier P; Parvaz P; Guichard S; Ducerf C; Baulieux J; Zoulim F; Trepo C
Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.
Gut 2003;52(2):283-7.
-
2003: Thermet Alexandre; Rollier Christine; Zoulim Fabien; Trepo Christian; Cova Lucyna
Progress in DNA vaccine for prophylaxis and therapy of hepatitis B.
Vaccine 2003;21(7-8):659-62.
-
2003: Trepo Christian; Maynard Marianne; Zoulim Fabien
Perspectives on therapy of hepatitis B.
Journal of hepatology 2003;39 Suppl 1():S220-3.
-
2003: Zoulim Fabien
Hepatitis B virus resistance to antivirals: clinical implications and management.
Journal of hepatology 2003;39 Suppl 1():S133-8.
-
2002: Lok Anna S F; Zoulim Fabien; Locarnini Stephen; Mangia Alessandra; Niro Grazia; Decraemer Hilde; Maertens Geert; Hulstaert Frank; De Vreese Karen; Sablon Erwin
Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
Journal of clinical microbiology 2002;40(10):3729-34.
-
2002: Seignères Béatrice; Pichoud Christian; Martin Perrine; Furman Philip; Trépo Christian; Zoulim Fabien
Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.
Hepatology (Baltimore, Md.) 2002;36(3):710-22.
-
2002: Escuret Vanessa; Parvaz Parviz; Hantz Olivier; Petit Marie-Anne; Trepo Christian; Zoulim Fabien
[Study of the antiviral mechanism of action of ribavirin in the bovine viral diarrhea virus model]
Gastroentérologie clinique et biologique 2002;26(6-7):584-90.
-
2002: Bailly François; Zoulim Fabien
[Chronic hepatitis B: natural history and treatments]
Gastroentérologie clinique et biologique 2002;26(5):492-500.
-
2002: Deugnier Yves; Loréal Olivier; Carré François; Duvallet Andre; Zoulim Fabien; Vinel Jean Pierre; Paris Jean Claude; Blaison Denis; Moirand Romain; Turlin Bruno; Gandon Yves; David Véronique; Mégret André; Guinot Michel
Increased body iron stores in elite road cyclists.
Medicine and science in sports and exercise 2002;34(5):876-80.
-
2002: Jeantet Damien; Chemin Isabelle; Mandrand Bernard; Zoulim Fabien; Trepo Christian; Kay Alan
Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient.
Hepatology (Baltimore, Md.) 2002;35(5):1215-24.
-
2002: Zoulim Fabien
[Treatment of patients with chronic hepatitis C who relapsed or did not respond to a previous treatment]
Gastroentérologie clinique et biologique 2002;26 Spec No 2():B225-30.
-
2002: Delmas Julien; Schorr Olivier; Jamard Catherine; Gibbs Craig; Trépo Christian; Hantz Olivier; Zoulim Fabien
Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.
Antimicrobial agents and chemotherapy 2002;46(2):425-33.
-
2002: Zoulim Fabien
[Toward the expected development of therapeutic combinations in hepatitis B?]
Gastroentérologie clinique et biologique 2002;26(1):107-8.
-
2002: Zoulim Fabien
Quantification and genotyping in management of chronic hepatitis B and C.
Virus research 2002;82(1-2):45-52.
-
2002: Zoulim Fabien
Assessing hepatitis B virus resistance in vitro and molecular mechanisms of nucleoside resistance.
Seminars in liver disease 2002;22 Suppl 1():23-31.
-
2002: Zoulim Fabien
A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection.
Drug safety : an international journal of medical toxicology and drug experience 2002;25(7):497-510.
-
2001: Borel C; Schorr O; Durand I; Zoulim F; Kay A; Trepo C; Hantz O
Initial amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of embryonic duck hepatocytes is increased by cell cycle progression.
Hepatology (Baltimore, Md.) 2001;34(1):168-79.
-
2001: Zoulim F
Detection of hepatitis B virus resistance to antivirals.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;21(3):243-53.
-
2001: Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng Y C; Zoulim F
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
Antimicrobial agents and chemotherapy 2001;45(4):1065-77.
-
2001: Chemin I; Zoulim F; Merle P; Arkhis A; Chevallier M; Kay A; Cova L; Chevallier P; Mandrand B; Trépo C
High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology.
Journal of hepatology 2001;34(3):447-54.
-
2001: Querenghi F; Yu Q; Billaud G; Maertens G; Trépo C; Zoulim F
Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy.
Journal of viral hepatitis 2001;8(2):120-31.
-
2001: Bain C; Fatmi A; Zoulim F; Zarski J P; Trépo C; Inchauspé G
Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection.
Gastroenterology 2001;120(2):512-24.
-
2001: Seignères B; Aguesse-Germon S; Pichoud C; Vuillermoz I; Jamard C; Trépo C; Zoulim F
Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo.
Journal of hepatology 2001;34(1):114-22.
-
2001: Zoulim F
Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
Antiviral chemistry & chemotherapy 2001;12 Suppl 1():131-42.
-
2000: Merle P; Zoulim F; Vitvitski L; Trépo C
[The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis]
Gastroentérologie clinique et biologique 2000;24(12):1166-76.
-
2000: Nafa S; Ahmed S; Tavan D; Pichoud C; Berby F; Stuyver L; Johnson M; Merle P; Abidi H; Trépo C; Zoulim F
Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
Hepatology (Baltimore, Md.) 2000;32(5):1078-88.
-
2000: Grandjacques C; Pradat P; Stuyver L; Chevallier M; Chevallier P; Pichoud C; Maisonnas M; Trépo C; Zoulim F
Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity.
Journal of hepatology 2000;33(3):430-9.
-
2000: Seignères B; Pichoud C; Ahmed S S; Hantz O; Trépo C; Zoulim F
Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.
The Journal of infectious diseases 2000;181(4):1221-33.
-
2000: Hantz O; Kraus J L; Zoulim F
Design and evaluation of hepatitis B virus inhibitors.
Current pharmaceutical design 2000;6(5):503-23.
-
2000: Pichoud C; Berby F; Stuyver L; Petit M A; Trépo C; Zoulim F
Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B.
Journal of hepatology 2000;32(2):307-16.
-
2000: Le Guerhier F; Pichoud C; Guerret S; Chevallier M; Jamard C; Hantz O; Li X Y; Chen S H; King I; Trépo C; Cheng Y C; Zoulim F
Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.
Antimicrobial agents and chemotherapy 2000;44(1):111-22.
-
1999: Zoulim F
Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies.
Antiviral research 1999;44(1):1-30.
-
1999: Broussolle C; Steineur M P; Bailly F; Zoulim F; Trépo C
[Hepatitis C virus infection and thyroid diseases]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1999;20(9):766-73.
-
1999: Romand F; Michallet M; Pichoud C; Trépo C; Zoulim F
[Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously cured of hepatitis B]
Gastroentérologie clinique et biologique 1999;23(6-7):770-4.
-
1999: Hantz O; Périgaud C; Borel C; Jamard C; Zoulim F; Trépo C; Imbach J L; Gosselin G
The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
Antiviral research 1999;40(3):179-87.
-
1999: Pichoud C; Seignères B; Wang Z; Trépo C; Zoulim F
Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance.
Hepatology (Baltimore, Md.) 1999;29(1):230-7.
-
1998: Habersetzer F; Zoulim F; Jusot J F; Zhang X; Trabaud M A; Chevallier P; Chevallier M; Ahmed S N; Sepetjan M; Comanor L; Minor J; Trépo C
Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alpha.
Journal of viral hepatitis 1998;5(6):407-14.
-
1998: Zoulim F; Haem J; Ahmed S S; Chossegros P; Habersetzer F; Chevallier M; Bailly F; Trépo C
Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients.
Journal of viral hepatitis 1998;5(3):193-8.
-
1998: Aguesse-Germon S; Liu S H; Chevallier M; Pichoud C; Jamard C; Borel C; Chu C K; Trépo C; Cheng Y C; Zoulim F
Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.
Antimicrobial agents and chemotherapy 1998;42(2):369-76.
-
1998: Trabaud C; Dessolin J; Camplo M; Hantz O; Zoulim F; Borel C; Meyer M; Pepe G; Chermann J C; Kraus J L
Design, synthesis and structure relationships of new N,N',N",N"'-tetrakis (omega-amino alkyl) tetraazamacrocycles.
Antiviral chemistry & chemotherapy 1998;9(1):73-84.
-
1997: Hantz O; Borel C; Trabaud C; Zoulim F; Dessolin J; Camplo M; Vlieghe P; Bouygues M; Trepo C; Kraus J L
Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles.
Antimicrobial agents and chemotherapy 1997;41(11):2579-81.
-
1997: Dumortier J; Durupt S; Chevallier M; Trépo C; Zoulim F
[Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir]
Gastroentérologie clinique et biologique 1997;21(12):982-6.
-
1996: Zoulim F; Zhang X; Pichoud C; Trepo C
Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc.
Journal of hepatology 1996;24(2):155-60.
-
1996: Zoulim F; Dannaoui E; Borel C; Hantz O; Lin T S; Liu S H; Trépo C; Cheng Y C
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
Antimicrobial agents and chemotherapy 1996;40(2):448-53.
-
1996: Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C
Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
Journal of medical virology 1996;48(1):8-16.
-
1995: Zoulim F; Capel F; Berthillon P; Trépo C; Petit M A
[Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B]
Gastroentérologie clinique et biologique 1995;19(12):970-5.
-
1995: Lamelin J P; Zoulim F; Trépo C
Lymphotropism of hepatitis B and C viruses: an update and a newcomer.
International journal of clinical & laboratory research 1995;25(1):1-6.
-
1994: Petit M A; Zoulim F; Berthillon P; Capel F; Li J; Dauguet C; Ferrari C; Trépo C
PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B.
Journal of hepatology 1994;20(1):47-56.
-
1994: Chemin I; Vermot-Desroches C; Baginski I; Saurin J C; Laurent F; Zoulim F; Bernaud J; Lamelin J P; Hantz O; Rigal D
Selective detection of human hepatitis B virus surface and core antigens in peripheral blood mononuclear cell subsets by flow cytometry.
Journal of viral hepatitis 1994;1(1):39-44.
-
1993: Causse X; Godinot H; Chevallier M; Chossegros P; Zoulim F; Zarski J P; Meschiewitz C; Albrecht J; Trépo C
Simultaneous steroids/interferon therapy in chronic hepatitis B.
Journal of hepatology 1993;17(1):128-9.
-
1993: Trépo C; Zoulim F; Alonso C; Petit M A; Pichoud C; Vitvitski L
Diagnostic markers of viral hepatitis B and C.
Gut 1993;34(2 Suppl):S20-5.
-
1992: Bouffard P; Lamelin J P; Zoulim F; Lepot D; Trepo C
Phytohemagglutinin and concanavalin A activate hepatitis B virus in peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection.
Journal of medical virology 1992;37(4):255-62.
-
1992: Zoulim F; Mimms L; Floreani M; Pichoud C; Chemin I; Kay A; Vitvitski L; Trepo C
New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.
Journal of clinical microbiology 1992;30(5):1111-9.
-
1992: Gaudin J L; Causse X; Zoulim F; Chevallier M; Trépo C
[Recovery of chronic hepatitis B- delta infection by zidovudine and recombinant interferon alpha combination therapy in a patient with Kaposi's sarcoma associated with HIV infection]
Gastroentérologie clinique et biologique 1992;16(5):468-72.
-
1992: Chemin I; Vermot-Desroches C; Baginski I; Saurin J C; Laurent F; Zoulim F; Bernaud J; Lamelin J P; Hantz O; Rigal D
Selective detection of human hepatitis B virus surface and core antigens in some peripheral blood mononuclear cell subsets by flow cytometry.
Journal of clinical & laboratory immunology 1992;38(2):63-71.
-
1992: Zoulim F; Li J; Baginski I; Lamelin J P; Trépo C
[Enzymatic amplification of sequences of viral nucleic acids. A methodological revolution promising new prospects in hepatology]
Gastroentérologie clinique et biologique 1992;16(5):443-53.
-
1992: Petit M A; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
Archives of virology. Supplementum 1992;4():105-12.
-
1991: Causse X; Godinot H; Chevallier M; Chossegros P; Zoulim F; Ouzan D; Heyraud J P; Fontanges T; Albrecht J; Meschievitz C
Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.
Gastroenterology 1991;101(2):497-502.
-
1991: Zoulim F; Vitvitski L; Bouffard P; Pichoud C; Rougier P; Lamelin J P; Trépo C
Detection of pre-S1 proteins in peripheral blood mononuclear cells from patients with HBV infection.
Journal of hepatology 1991;12(2):150-6.
-
1991: Chemin I; Baginski I; Petit M A; Zoulim F; Pichoud C; Capel F; Hantz O; Trepo C
Correlation between HBV DNA detection by polymerase chain reaction and Pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infections.
Journal of medical virology 1991;33(1):51-7.
-
1990: Li J; Tong S; Vitvitski L; Zoulim F; Trépo C
Rapid detection and further characterization of infection with hepatitis B virus variants containing a stop codon in the distal pre-C region.
The Journal of general virology 1990;71 ( Pt 9)():1993-8.
-
1990: Bouffard P; Lamelin J P; Zoulim F; Pichoud C; Trepo C
Different forms of hepatitis B virus DNA and expression of HBV antigens in peripheral blood mononuclear cells in chronic hepatitis B.
Journal of medical virology 1990;31(4):312-7.
-
1990: Jenhani F; Ayed K; Gorgi Y; Zoulim F; Pichoud C; Trepo C
Delta infection in chronic HBs Ag carriers in Tunisia: high prevalence in chronic asymptomatic HBs Ag carriers and in HBs Ag positive cirrhosis.
Annals of tropical medicine and parasitology 1990;84(4):349-53.
-
1990: Petit M A; Zoulim F; Capel F; Dubanchet S; Dauguet C; Trepo C
Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication.
Hepatology (Baltimore, Md.) 1990;11(5):809-14.
-
1990: Zoulim F; Lamelin J P; Trepo C
[Clinical implications of interactions between hepatitis B virus and mononuclear leukocytes]
Gastroentérologie clinique et biologique 1990;14(3):255-62.
-
1990: Trépo C; Chemin I; Petit M A; Chossegros P; Zoulim F; Chevallier P; Sepetjan M
Possible prevention of chronic hepatitis B by early interferon therapy.
Journal of hepatology 1990;11 Suppl 1():S95-9.
-
1989: Zoulim F; Vitvitski L; Pichoud C; Lamelin J P; Trépo C
[Significance of the expression of pre-S proteins in mononuclear blood cells in chronic hepatitis caused by the hepatitis B virus]
Gastroentérologie clinique et biologique 1989;13(8-9):707-11.
Sign-in to see more
